What is he best known for?
The fields of study he is best known for:
His primary areas of investigation include Metastasis, Cell biology, Cancer research, Cancer cell and Mitophagy.
His Metastasis study integrates concerns from other disciplines, such as KEAP1, Lung cancer and Ubiquitin ligase.
His Cancer research research integrates issues from Haematopoiesis, Ubiquitin, NFE2L2, Transcription factor and Epigenetics.
His work in Epigenetics addresses issues such as Histone, which are connected to fields such as Gene silencing.
His Cancer cell research includes themes of Tumor microenvironment and Cancer stem cell.
His Mitophagy research is multidisciplinary, relying on both Reverse Warburg effect, Warburg effect and Stromal cell.
His most cited work include:
- Dynamic changes in the human methylome during differentiation (803 citations)
- DNA methylation-based classification of central nervous system tumours (733 citations)
- Classification and mutation prediction from non-small cell lung cancer histopathology images using deep learning. (656 citations)
What are the main themes of his work throughout his whole career to date?
Aristotelis Tsirigos mainly investigates Cancer research, Cell biology, Chromatin, Gene and Epigenetics.
The Cancer research study combines topics in areas such as Cancer, Tumor microenvironment, Immune system, Metastasis and Immunotherapy.
His Metastasis study combines topics in areas such as Cancer cell, Warburg effect, Stromal cell and Mitophagy.
His studies deal with areas such as Reprogramming, Transcription factor, Cohesin, Induced pluripotent stem cell and Regulation of gene expression as well as Cell biology.
His study with Gene involves better knowledge in Genetics.
His Epigenetics research integrates issues from Histone, Methylation, Signal transduction and DNA methylation.
He most often published in these fields:
- Cancer research (31.82%)
- Cell biology (25.76%)
- Chromatin (17.17%)
What were the highlights of his more recent work (between 2019-2021)?
- Cancer research (31.82%)
- Epigenetics (15.15%)
- Cell biology (25.76%)
In recent papers he was focusing on the following fields of study:
Aristotelis Tsirigos mostly deals with Cancer research, Epigenetics, Cell biology, Chromatin and Immunotherapy.
Aristotelis Tsirigos combines subjects such as Cell, Cytotoxic T cell, Metastasis and Immune system with his study of Cancer research.
Epigenetics is a subfield of Gene that Aristotelis Tsirigos investigates.
His research in Gene intersects with topics in Molecular biology and Tumour heterogeneity.
His biological study spans a wide range of topics, including CTCF, Transcription factor, Cohesin, Induced pluripotent stem cell and Regulation of gene expression.
The various areas that Aristotelis Tsirigos examines in his Chromatin study include Enhancer, Mitosis and Stem cell.
Between 2019 and 2021, his most popular works were:
- Epigenetic Silencing of CDR1as Drives IGF2BP3-Mediated Melanoma Invasion and Metastasis. (49 citations)
- In Vivo Epigenetic CRISPR Screen Identifies Asf1a as an Immunotherapeutic Target in Kras-Mutant Lung Adenocarcinoma (33 citations)
- Three-dimensional chromatin landscapes in T cell acute lymphoblastic leukemia. (27 citations)
In his most recent research, the most cited papers focused on:
The scientist’s investigation covers issues in Cell biology, Cancer research, Epigenetics, Regulation of gene expression and Immunotherapy.
His Cell biology research is multidisciplinary, incorporating perspectives in Exon skipping and Chromatin, Post-translational regulation, Gene, Cohesin.
In his research, Aristotelis Tsirigos undertakes multidisciplinary study on Cancer research and B-cell acute lymphoblastic leukemia.
His study focuses on the intersection of Epigenetics and fields such as CTCF with connections in the field of DNA methylation, Genomic organization, Genome, Function and DECIPHER.
His Regulation of gene expression research is multidisciplinary, incorporating elements of Ubiquitin, Ubiquitin ligase, Pancreatic cancer, Cancer cell and Nucleosome.
Aristotelis Tsirigos interconnects Tumor microenvironment, Lung cancer, Autoimmunity and CRISPR in the investigation of issues within Immunotherapy.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
